ロード中...
Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
BACKGROUND: Tuberculosis causes more deaths than any other infectious disease worldwide, with pulmonary tuberculosis being the most common form. Standard first‐line treatment for drug‐sensitive pulmonary tuberculosis for six months comprises isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE)...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2019
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953336/ https://ncbi.nlm.nih.gov/pubmed/31828771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012918.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|